Impact of the U.S. preventive services task force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates

Journal of Urology

Volumn 193, Issue 5, 2015, Pages 1519-1524

  Bhindi, Bimal ^a   Mamdani, Muhammad ^d   Kulkarni, Girish S ^a,c   Finelli, Antonio ^a   Hamilton, Robert J ^a   Trachtenberg, John ^a   Zlotta, Alexandre R ^a   Evans, Andrew ^b   Van Der Kwast, Theodorus H ^b   Toi, Ants ^b   Fleshner, Neil E ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

biopsy; early detection of cancer; prostate; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SCREENING; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVENTIVE HEALTH SERVICE; PREVENTIVE SERVICES TASK FORCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TIME SERIES ANALYSIS; UNITED STATES; BIOPSY; BLOOD; EARLY DIAGNOSIS; EVALUATION STUDY; PATHOLOGY; PRACTICE GUIDELINE; PROSTATE TUMOR; STANDARDS; STATISTICS AND NUMERICAL DATA; TIME;

AGED; BIOPSY; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 84927910147     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.11.096     Document Type: Article

References (30)

1. T.A. Stamey, N. Yang, and A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
2. A.L. Potosky, B.A. Miller, and P.C. Albertsen The role of increasing detection in the rising incidence of prostate cancer JAMA 273 1995 548
3. G.L. Andriole, E.D. Crawford, and R.L. Grubb 3rd Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310
4. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
5. J. Hugosson, S. Carlsson, and G. Aus Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2010 725
6. G.L. Andriole, E.D. Crawford, and R.L. Grubb 3rd Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 2012 125
7. F.H. Schroder, J. Hugosson, and M.J. Roobol Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 2012 981
8. V.A. Moyer U.S. Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120
9. S. Payton Prostate cancer: new PSA screening guideline faces widespread opposition Nat Rev Urol 9 2012 351
10. W.J. Catalona, A.V. D'Amico, and W.F. Fitzgibbons What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation Ann Intern Med 157 2012 137
11. O.W. Brawley Prostate cancer screening: what we know, don't know, and believe Ann Intern Med 157 2012 135
12. N.A. Hoag, and A.I. So The confusion surrounding prostate cancer screening faced by family physicians Can Urol Assoc J 6 2012 194
13. B. Bhindi, G.S. Kulkarni, and A. Finelli Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly Eur Urol 66 2014 841
14. P.C. Albertsen, J.A. Hanley, and J. Fine 20-Year outcomes following conservative management of clinically localized prostate cancer JAMA 293 2005 2095
15. A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708
16. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203
17. D.N. Juurlink, M.M. Mamdani, and D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543
18. M. Ordon, D. Urbach, and M. Mamdani The surgical management of kidney stone disease: a population-based time series analysis J Urol 192 2014 1450
19. A.M. Wolf, R.C. Wender, and R.B. Etzioni American Cancer Society guideline for the early detection of prostate cancer: update 2010 CA Cancer J Clin 60 2010 70
20. J.I. Izawa, L. Klotz, and D.R. Siemens Prostate cancer screening: Canadian guidelines 2011 Can Urol Assoc J 5 2011 235
21. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61
22. H.B. Carter, P.C. Albertsen, and M.J. Barry Early detection of prostate cancer: AUA guideline J Urol 190 2013 419
23. A. Qaseem, M.J. Barry, and T.D. Denberg Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians Ann Intern Med 158 2013 761
24. E. Basch, T.K. Oliver, and A. Vickers Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology provisional clinical opinion J Clin Oncol 30 2012 3020
25. A. Heidenreich, P.J. Bastian, and J. Bellmunt EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013 Eur Urol 65 2014 124
26. L.B. Squiers, C.M. Bann, and S.E. Dolina Prostate-specific antigen testing: men's responses to 2012 recommendation against screening Am J Prev Med 45 2013 182
27. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
28. P. Warde, M. Mason, and K. Ding Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial Lancet 378 2011 2104
29. A. Aslani, B.J. Minnillo, and B. Johnson The impact of recent screening recommendations on prostate cancer screening in a large health care system J Urol 191 2014 1737
30. J.A. Cohn, C.E. Wang, and J.C. Lakeman Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation Urol Oncol 32 2014 41